UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000044549
Receipt number R000050822
Scientific Title An open-label, single arm study assessing the usefulness of forward-viewing echoendoscope and difficulty factors for specimen collection in endoscopic ultrasound-guided fine-needle aspiration of gastric subepithelial lesions
Date of disclosure of the study information 2021/06/16
Last modified on 2022/06/16 13:27:31

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

An open-label, single arm study assessing the usefulness of forward-viewing echoendoscope and difficulty factors for specimen collection in endoscopic ultrasound-guided fine-needle aspiration of gastric subepithelial lesions

Acronym

Flower study

Scientific Title

An open-label, single arm study assessing the usefulness of forward-viewing echoendoscope and difficulty factors for specimen collection in endoscopic ultrasound-guided fine-needle aspiration of gastric subepithelial lesions

Scientific Title:Acronym

Flower study

Region

Japan


Condition

Condition

gastric subepithelial lesion

Classification by specialty

Gastroenterology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To verify the usefulness of EUS-FNA for gastric subepithelial lesions using a forward-viewing echoendoscope and factors that make specimen collection difficult

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

The rate of specimens successfully collected with a forward-viewing echoendoscope

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

(1) Gastric SEL patients who are scheduled to undergo EUS-FNA and have a tumor diameter of 10 mm or more.
(2) 20 years old or older.
(3) The patient's free written consent to participate in this study has been obtained after sufficient explanation.

Key exclusion criteria

(1) Patients who are taking antithrombotic drugs and are unable to take a drug withdrawal or substitution in accordance with the "Guidelines for Gastrointestinal Endoscopy Care for Patients Taking Antithrombotic Drugs".
(2) Patients who are unable to give their consent for this study.
(3) Patients who are judged by the principal investigator to be unsuitable for this study.

Target sample size

48


Research contact person

Name of lead principal investigator

1st name Takuto
Middle name
Last name Hikichi

Organization

Fukushima Medical University Hospital

Division name

Department of Endoscopy

Zip code

960-1295

Address

1 Hikarigaoka, Fukushima, 960-1295, Japan

TEL

0245471583

Email

takuto@fmu.ac.jp


Public contact

Name of contact person

1st name Minami
Middle name
Last name Hashimoto

Organization

Fukushima Medeical University Hospital

Division name

Department of Endoscopy

Zip code

960-1295

Address

1 Hikarigaoka, Fukushima, 960-1295, Japan

TEL

0245471583

Homepage URL


Email

mi-hashi@fmu.ac.jp


Sponsor or person

Institute

Department of Endoscopy, Fukushima Medeical University Hospital

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Fukushima Medeical University Hospital

Address

1 Hikarigaoka, Fukushima, 960-1295, Japan

Tel

0245471583

Email

mi-hashi@fmu.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2021 Year 06 Month 16 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2020 Year 07 Month 28 Day

Date of IRB

2020 Year 09 Month 15 Day

Anticipated trial start date

2020 Year 09 Month 15 Day

Last follow-up date

2025 Year 08 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

None


Management information

Registered date

2021 Year 06 Month 15 Day

Last modified on

2022 Year 06 Month 16 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000050822


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name